Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Early Pitavastatin Therapy on Coronary Fibrous-Cap Thickness Assessed by Optical Coherence Tomography in Patients With Acute Coronary Syndrome: The ESCORT Study.
Nishiguchi T, Kubo T, Tanimoto T, Ino Y, Matsuo Y, Yamano T, Terada K, Emori H, Katayama Y, Taruya A, Ozaki Y, Shiono Y, Shimamura K, Kameyama T, Kitabata H, Yamaguchi T, Tanaka A, Hozumi T, Akasaka T. Nishiguchi T, et al. Among authors: terada k. JACC Cardiovasc Imaging. 2018 Jun;11(6):829-838. doi: 10.1016/j.jcmg.2017.07.011. Epub 2017 Sep 13. JACC Cardiovasc Imaging. 2018. PMID: 28917689 Free article. Clinical Trial.
Clinical Utility of Combined Optical Coherence Tomography and Near-Infrared Spectroscopy for Assessing the Mechanism of Very Late Stent Thrombosis.
Ino Y, Kubo T, Kameyama T, Shimamura K, Terada K, Matsuo Y, Kitabata H, Shiono Y, Kashiwagi M, Kuroi A, Maniwa N, Ota S, Ozaki Y, Tanaka A, Hozumi T, Akasaka T. Ino Y, et al. Among authors: terada k. JACC Cardiovasc Imaging. 2018 May;11(5):772-775. doi: 10.1016/j.jcmg.2017.11.015. Epub 2018 Jan 17. JACC Cardiovasc Imaging. 2018. PMID: 29361480 Free article. No abstract available.
The relationship between timing of prasugrel pretreatment and in-stent thrombus immediately after percutaneous coronary intervention for acute coronary syndrome: an optical coherence tomography study.
Katayama Y, Kubo T, Ino Y, Kameyama T, Matsuo Y, Kitabata H, Terada K, Emori H, Aoki H, Taruya A, Shimamura K, Ota S, Tanaka A, Hozumi T, Akasaka T. Katayama Y, et al. Among authors: terada k. Heart Vessels. 2018 Oct;33(10):1159-1167. doi: 10.1007/s00380-018-1167-8. Epub 2018 Apr 24. Heart Vessels. 2018. PMID: 29691643
Usefulness of rescue ultrasound guidance for transradial cardiac catheterization.
Kashiwagi M, Tanimoto T, Kitabata H, Arita Y, Yamamoto Y, Mori K, Terada K, Nishiguchi T, Taruya A, Kubo T, Tanaka A, Akasaka T. Kashiwagi M, et al. Among authors: terada k. Cardiovasc Revasc Med. 2019 Apr;20(4):311-315. doi: 10.1016/j.carrev.2018.07.004. Epub 2018 Jul 5. Cardiovasc Revasc Med. 2019. PMID: 30007871
Retrospective Comparison of Long-Term Clinical Outcomes Between Percutaneous Coronary Intervention and Medical Therapy in Stable Coronary Artery Disease With Gray Zone Fractional Flow Reserve　- COMFORTABLE Retrospective Study.
Kubo T, Takahata M, Terada K, Mori K, Arita Y, Ino Y, Matsuo Y, Kitabata H, Shiono Y, Shimamura K, Kameyama T, Emori H, Katayama Y, Tanimoto T, Akasaka T. Kubo T, et al. Among authors: terada k. Circ J. 2018 Nov 24;82(12):3044-3051. doi: 10.1253/circj.CJ-18-0672. Epub 2018 Oct 13. Circ J. 2018. PMID: 30318503 Free article. Clinical Trial.
Association of Hemodynamic Severity With Plaque Vulnerability and Complexity of Coronary Artery Stenosis: A Combined Optical Coherence Tomography and Fractional Flow Reserve Study.
Matsuo Y, Higashioka D, Ino Y, Shiono Y, Kitabata H, Terada K, Emori H, Katayama Y, Taruya A, Nishiguchi T, Shimamura K, Kameyama T, Kuroi A, Yamano T, Tanimoto T, Tanaka A, Hozumi T, Kubo T, Akasaka T. Matsuo Y, et al. Among authors: terada k. JACC Cardiovasc Imaging. 2019 Jun;12(6):1103-1105. doi: 10.1016/j.jcmg.2018.11.023. Epub 2019 Jan 16. JACC Cardiovasc Imaging. 2019. PMID: 30660534 Free article. No abstract available.
Stabilization of High Risk Coronary Plaque on Optical Coherence Tomography and Near-Infrared Spectroscopy by Intensive Lipid-Lowering Therapy With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor.
Ino Y, Kubo T, Shimamura K, Takahata M, Matsuo Y, Kitabata H, Shiono Y, Wada T, Terada K, Katayama Y, Emori H, Higashioka D, Tanaka A, Hozumi T, Akasaka T. Ino Y, et al. Among authors: terada k. Circ J. 2019 Jul 25;83(8):1765. doi: 10.1253/circj.CJ-18-0983. Epub 2019 Feb 22. Circ J. 2019. PMID: 30799312 Free article. No abstract available.
1,171 results